Gilad Gershon
Chief Executive Officer at Tropic Biosciences UK Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Erez Vigodman | M | 64 |
Tropic Biosciences UK Ltd.
 Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom.
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| David Venables | M | - |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Elsy Boglioli Hofman | F | 42 |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Eyal Maori | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Ofir Meir | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| David Lawrence | M | 75 |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| John Brown | M | 69 |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | - |
| Ben Belldegrun | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| David Charles Baulcombe | M | 72 |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Niccolo Manzoni | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Vincent Pétiard | M | - |
Tropic Biosciences UK Ltd.
Tropic Biosciences UK Ltd. Agricultural Commodities/MillingProcess Industries Tropic Biosciences UK Ltd. develops varieties of tropical crops by utilizing cutting-edge genome editing technologies. The company is headquartered in Norwich, the United Kingdom. | - |
| Tom Payne | M | - |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | 3 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gilad Gershon
- Personal Network
